Table 5. Summary of RAS to any DAA genotype in 1b by time point.
Baseline | Post failure | |
---|---|---|
Resistance to NS5a inhibitors | N=13 | N=2 |
30: R30Q | 1 (8%) | - |
31: L31I | 1 (8%) | - |
L31M | 1 (8%) | - |
37: L37I | 1 (8%) | - |
54: Q54H | 11 (84%) | 2 (100%) |
58: P58S | 1 (8%) | - |
Resistance to NS5b inhibitors | N=10 | N=3 |
159: L159F | 5 (50%) | 1 (33%) |
316: C316H | 2 (20%) | 1 (33%) |
C316N | 4 (40%) | 1 (33%) |
556: S556G | 6 (60%) | 3 (100%) |
Resistance to protease inhibitors | N=2 | N=1 |
122: S122N | 1 (50%) | 1 (100%) |
168: D168E | 1 (50%) | - |